Answers are grounded in this paper and cite their sources.
Case report illustrates methotrexate's effectiveness in treating ovarian hyperstimulation syndrome due to ectopic pregnancy, suggesting reconsideration of its use in early diagnosis.
Introduction Ovarian hyperstimulation syndrome (OHSS) is typically caused by excessive ovarian stimulation during an in vitro fertilization protocol. Most cases of OHSS are early‐onset, mainly occurring after human chorionic gonadotropic (hCG) trigger, while late‐onset OHSS occurs with positive pregnancy. Very few cases of OHSS occurring due to ectopic pregnancy have been reported. Presentation of Case We present the case of a 31‐year‐old female patient who presented for OHSS symptoms. Her beta‐hCG levels kept ranging from 85 to 129 IU/mL. She was maintained on restricted fluid intake, intravenous albumin, cabergoline 0.5 mg daily, and enoxaparin sodium injection 40 mg subcutaneously every day with no significant improvement. After a week of expectant management, the beta‐hCG level did not go down, and ectopic pregnancy was suspected. The decision at that time was to give 75 mg intramuscular methotrexate as a single dose. 1 week after the methotrexate dose, her beta‐hCG level went down and her laboratory tests all normalized. On ultrasound, the size of the ovaries went back to the normal range. Conclusion There are very few studies around the world discussing the occurrence of OHSS with suspected ectopic pregnancy and the management course to be taken, making this case report unique and raising questions around the diagnosis and treatment of suspected ectopic pregnancy in its very early course with OHSS complications.
No takes yet. Share an insight, caveat, or question.
Saliba et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: